-
Je něco špatně v tomto záznamu ?
Importance of proapoptotic protein PUMA in cell radioresistance
J. Vávrová, M. Řezáčová
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
NLK
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
ProQuest Central
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
- MeSH
- apoptóza účinky léků MeSH
- benzothiazoly farmakologie MeSH
- kontrolní body buněčného cyklu účinky léků MeSH
- myši MeSH
- nádorové supresorové proteiny genetika metabolismus MeSH
- proteiny regulující apoptózu genetika metabolismus MeSH
- protoonkogenní proteiny genetika metabolismus MeSH
- toluen analogy a deriváty farmakologie MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Protein p53 plays an essential role in the induction of apoptosis by ionizing radiation in haemopoietic cells, the damage of which is the main reason for the development of bone marrow post-irradiation syndrome. p53 activation leads to an increase in the Bcl-2 family pro-apoptotic protein PUMA level. PUMA inhibits all the five anti-apoptotic proteins (Mcl-1, Bcl-2, Bcl-XL, Bcl-W and A1) and directly triggers apoptosis mediated by pro-apoptotic proteins Bax/Bak. In proliferating cells, knockout of p53 inhibits apoptosis on the one hand, but on the other disables the cellular division arrest moderated by p21Cip1/Waf1. The radioprotective effect of p53 inhibitor pifithrin was obvious at radiation doses causing the bone marrow syndrome. Knockout of PUMA also exerts its radioprotective effect through blocking the apoptosis induction, but the arrest of cells in the cell cycle through p21 induction is not abolished. PUMA -/- mice are radioresistant in terms of the development of post-irradiation syndrome after all radiation doses. Small molecules are being searched for that could prevent binding of PUMA with Bcl-2 family anti-apoptotic proteins. This would result in apoptosis inhibition and radioprotective or mitigating effects of these inhibitors.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14083252
- 003
- CZ-PrNML
- 005
- 20170322101131.0
- 007
- ta
- 008
- 150102s2014 xr d f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)24785107
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Vávrová, Jiřina, $7 xx0004363 $d 1946- $u Department of Radiobiology, Faculty of Military Health Sciences in Hradec Králové, University of Defence in Brno, Hradec Králové, Czech Republic
- 245 10
- $a Importance of proapoptotic protein PUMA in cell radioresistance / $c J. Vávrová, M. Řezáčová
- 520 9_
- $a Protein p53 plays an essential role in the induction of apoptosis by ionizing radiation in haemopoietic cells, the damage of which is the main reason for the development of bone marrow post-irradiation syndrome. p53 activation leads to an increase in the Bcl-2 family pro-apoptotic protein PUMA level. PUMA inhibits all the five anti-apoptotic proteins (Mcl-1, Bcl-2, Bcl-XL, Bcl-W and A1) and directly triggers apoptosis mediated by pro-apoptotic proteins Bax/Bak. In proliferating cells, knockout of p53 inhibits apoptosis on the one hand, but on the other disables the cellular division arrest moderated by p21Cip1/Waf1. The radioprotective effect of p53 inhibitor pifithrin was obvious at radiation doses causing the bone marrow syndrome. Knockout of PUMA also exerts its radioprotective effect through blocking the apoptosis induction, but the arrest of cells in the cell cycle through p21 induction is not abolished. PUMA -/- mice are radioresistant in terms of the development of post-irradiation syndrome after all radiation doses. Small molecules are being searched for that could prevent binding of PUMA with Bcl-2 family anti-apoptotic proteins. This would result in apoptosis inhibition and radioprotective or mitigating effects of these inhibitors.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a proteiny regulující apoptózu $x genetika $x metabolismus $7 D051017
- 650 _2
- $a benzothiazoly $x farmakologie $7 D052160
- 650 _2
- $a kontrolní body buněčného cyklu $x účinky léků $7 D059447
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a protoonkogenní proteiny $x genetika $x metabolismus $7 D011518
- 650 _2
- $a toluen $x analogy a deriváty $x farmakologie $7 D014050
- 650 _2
- $a nádorové supresorové proteiny $x genetika $x metabolismus $7 D025521
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Řezáčová, Martina, $d 1972- $7 nlk20020124956 $u Department of Medical Biochemistry, Faculty of Medicine in Hradec Králové, Charles University in Prague, Hradec Králové, Czech Republic
- 773 0_
- $w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 60, č. 2 (2014), s. 53-56
- 856 41
- $u https://fb.cuni.cz/file/5715/FB2014A0007.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 970 $c 89 $y 4 $z 0
- 990 __
- $a 20150102 $b ABA008
- 991 __
- $a 20170322101403 $b ABA008
- 999 __
- $a ok $b bmc $g 1057924 $s 882360
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 60 $c 2 $d 53-56 $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
- LZP __
- $b NLK118 $a Pubmed-20150102